Cetrorelix (Cetrotide)

DRUG3 trials

Sponsors

Aristotle University Of Thessaloniki, Eugonia, Kasr El Aini Hospital

Conditions

Assisted Reproductive TechniquesGnRH AntagonistOvarian Hyperstimulation SyndromePPOSSubfertility

Phase 3

PPOS Protocol Versus GnRH Anatagonist for Expected Normal Responder Patients Undergoing ART : a Randomized Clinical Trial

CompletedNCT06868576

Kasr El Aini HospitalAssisted Reproductive Techniques, GnRH Antagonist, PPOS

Start: 2023-01-03End: 2025-02-28Updated: 2025-03-11

Phase 4

Fixed Versus Flexible Gonadotropin-releasing Hormone (GnRH) Antagonist Initiation

CompletedNCT01005784

Aristotle University Of ThessalonikiSubfertility

Start: 2005-06-30End: 2008-03-31Updated: 2009-11-02

Unknown Phase

Luteal Antagonist Versus Conventional Treatment in Women With Severe Early Ovarian Hyperstimulation Syndrome (OHSS)

EugoniaOvarian Hyperstimulation Syndrome

Start: 2015-05-31End: 2016-12-31Target: 40Updated: 2015-03-19